Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Laser treatment effectively increases hair density and thickness in androgenic alopecia.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

The Third World Congress of the International Academy of Cosmetic Dermatology discussed various topics like hair disorders, skin conditions, wound healing, shampoo technology, acne treatment, and the use of lasers in dermatology.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Androgenetic alopecia is more common in Saudi men than women.

Female pattern hair loss greatly affects women's quality of life, causing mild depression and anxiety, and increases medical expenses.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Hair transplants are highly satisfactory for treating female-pattern hair loss.